| http://www.w3.org/ns/prov#value | - We are interested in the extent to which the 2004 reforms have expanded the Europeanization of pharmaceuticals regulation in terms of the harmonization of standards, a further shift of regulatory decision-making authority to the European level, and an increase in the European character of the regulatory bodies, especially EMEA (now: EMA) and its Scientific Committee, CPMP (now:CHMP).
|
